150 related articles for article (PubMed ID: 29234152)
21. Up-Regulated Expression of SPRY4-IT1 Predicts Poor Prognosis in Colorectal Cancer.
Tan W; Song ZZ; Xu Q; Qu X; Li Z; Wang Y; Yu Q; Wang S
Med Sci Monit; 2017 Jan; 23():309-314. PubMed ID: 28099409
[TBL] [Abstract][Full Text] [Related]
22. Prognostic role of the long non-coding RNA, SPRY4 Intronic Transcript 1, in patients with cancer: a meta-analysis.
Wang M; Dong X; Feng Y; Sun H; Shan N; Lu T
Oncotarget; 2017 May; 8(20):33713-33724. PubMed ID: 28410241
[TBL] [Abstract][Full Text] [Related]
23. Potential diagnostic value of lncRNA SPRY4-IT1 in hepatocellular carcinoma.
Jing W; Gao S; Zhu M; Luo P; Jing X; Chai H; Tu J
Oncol Rep; 2016 Aug; 36(2):1085-92. PubMed ID: 27278245
[TBL] [Abstract][Full Text] [Related]
24. SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma.
Xu Y; Yao Y; Jiang X; Zhong X; Wang Z; Li C; Kang P; Leng K; Ji D; Li Z; Huang L; Qin W; Cui Y
J Exp Clin Cancer Res; 2018 Apr; 37(1):81. PubMed ID: 29642935
[TBL] [Abstract][Full Text] [Related]
25. SPRY4-IT1: A novel oncogenic long non-coding RNA in human cancers.
Li J; Chen Y; Chen Z; He A; Xie H; Zhang Q; Cai Z; Liu Y; Huang W
Tumour Biol; 2017 Jun; 39(6):1010428317711406. PubMed ID: 28651500
[TBL] [Abstract][Full Text] [Related]
26. LncRNA SPRY4-IT1 facilitates cell proliferation and angiogenesis of glioma via the miR-101-3p/EZH2/VEGFA signaling axis.
Wang J; Chen Y; Wang Q; Xu H; Jiang Q; Wang M; Li S; Chen Y; Wu C; Yu P; Xiao Z; Chen W; Lan Q
Cancer Med; 2023 Mar; 12(6):7309-7326. PubMed ID: 36479622
[TBL] [Abstract][Full Text] [Related]
27. [Effect of long noncoding RNA SPRY4-IT1 on proliferation and metastasis of medulloblastoma].
Shi PF; Ji HL; Luo YK; Mao TM; Chen X; Zhou KY
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 Jan; 33(1):78-82. PubMed ID: 29926610
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA SPRY4-IT1 pormotes colorectal cancer metastasis by regulate epithelial-mesenchymal transition.
Shen F; Cai WS; Feng Z; Chen JW; Feng JH; Liu QC; Fang YP; Li KP; Xiao HQ; Cao J; Xu B
Oncotarget; 2017 Feb; 8(9):14479-14486. PubMed ID: 27391336
[TBL] [Abstract][Full Text] [Related]
29. Effects of long noncoding RNA SPRY4-IT1-mediated EZH2 on the invasion and migration of lung adenocarcinoma.
Wen X; Han XR; Wang YJ; Fan SH; Zhuang J; Zhang ZF; Shan Q; Li MQ; Hu B; Sun CH; Wu Q; Tan JH; Wu DM; Lu J; Zheng YL
J Cell Biochem; 2018 Feb; 119(2):1827-1840. PubMed ID: 28796375
[TBL] [Abstract][Full Text] [Related]
30. NF-κB-activated SPRY4-IT1 promotes cancer cell metastasis by downregulating TCEB1 mRNA via Staufen1-mediated mRNA decay.
Zhao L; Jiang L; Zhang M; Zhang Q; Guan Q; Li Y; He M; Zhang J; Wei M
Oncogene; 2021 Jul; 40(30):4919-4929. PubMed ID: 34163032
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of SPRY4-IT1 in efficacy and survival prediction in breast cancer patients undergoing neoadjuvant chemotherapy.
Zheng A; Zhang L; Song X; Jin F
Histol Histopathol; 2020 Apr; 35(4):361-370. PubMed ID: 31638266
[TBL] [Abstract][Full Text] [Related]
32. The long non-coding RNA SPRY4-IT1: An emerging player in tumorigenesis and osteosarcoma.
Li Z; Shen J; Chan MTV; Wu WKK
Cell Prolif; 2018 Aug; 51(4):e12446. PubMed ID: 29484753
[TBL] [Abstract][Full Text] [Related]
33. The functional characterization of long noncoding RNA SPRY4-IT1 in human melanoma cells.
Mazar J; Zhao W; Khalil AM; Lee B; Shelley J; Govindarajan SS; Yamamoto F; Ratnam M; Aftab MN; Collins S; Finck BN; Han X; Mattick JS; Dinger ME; Perera RJ
Oncotarget; 2014 Oct; 5(19):8959-69. PubMed ID: 25344859
[TBL] [Abstract][Full Text] [Related]
34. Long Non-Coding RNA SPRY4-IT1 Can Predict Poor Prognosis in Digestive System Malignancies: a Meta-Analysis.
Sun C; Ding Y; Wang S; Hu W
Pathol Oncol Res; 2019 Jan; 25(1):89-95. PubMed ID: 28965279
[TBL] [Abstract][Full Text] [Related]
35. Up-regulation of long non-coding RNA
Zhang X; Chi Q; Zhao Z
Oncotarget; 2017 Aug; 8(31):51058-51065. PubMed ID: 28881629
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA SPRY4-IT1 promotes cell proliferation and invasion by regulation of Cdc20 in pancreatic cancer cells.
Guo W; Zhong K; Wei H; Nie C; Yuan Z
PLoS One; 2018; 13(2):e0193483. PubMed ID: 29489909
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of long noncoding RNA SPRY4-IT1 correlates with tumor progression and poor prognosis in cervical cancer.
Cao Y; Liu Y; Lu X; Wang Y; Qiao H; Liu M
FEBS Open Bio; 2016 Sep; 6(9):954-60. PubMed ID: 27642559
[TBL] [Abstract][Full Text] [Related]
38. The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion.
Khaitan D; Dinger ME; Mazar J; Crawford J; Smith MA; Mattick JS; Perera RJ
Cancer Res; 2011 Jun; 71(11):3852-62. PubMed ID: 21558391
[TBL] [Abstract][Full Text] [Related]
39. Long Non-Coding RNA SPRY4-IT1 Can Predict Unfavorable Prognosis and Lymph Node Metastasis: a Meta-Analysis.
Li N; Tan Q; Jing W; Luo P; Tu J
Pathol Oncol Res; 2017 Oct; 23(4):731-736. PubMed ID: 28054316
[TBL] [Abstract][Full Text] [Related]
40. Deregulation of long noncoding RNAs ANCR, TINCR, HOTTIP and SPRY4-IT1 in plasma of systemic sclerosis patients: SPRY4-IT1 as a novel biomarker of scleroderma and its subtypes.
Abd-Elmawla MA; Hassan M; Elsabagh YA; Alnaggar ARLR; Senousy MA
Cytokine; 2020 Sep; 133():155124. PubMed ID: 32442909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
